Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
40 Gray in 5 Fractions for Salvage Reirradiation of Spine Lesions Previously Treated With Stereotactic Body Radiotherapy.
Moore A, Zhang Z, Fei T, Zhang L, Accomando L, Schmitt AM, Higginson DS, Mueller BA, Zinovoy M, Gelblum DY, Yerramilli D, Xu AJ, Brennan VS, Guttmann DM, Grossman CE, Dover LL, Shaverdian N, Pike LRG, Cuaron JJ, Dreyfuss A, Lis E, Barzilai O, Bilsky MH, Yamada Y. Moore A, et al. Among authors: brennan vs. Neurosurgery. 2024 Aug 1;95(2):380-391. doi: 10.1227/neu.0000000000002889. Epub 2024 Mar 8. Neurosurgery. 2024. PMID: 38456696
Personalized Treatment Selection Leads to Low Rates of Local Salvage Therapy for Bone Metastases.
Mathis NJ, Doyle CJ, Rosen DB, Wijetunga NA, Vaynrub M, Bartelstein M, Guttmann DM, Brennan VS, Yamada YJ, Gillespie EF, Yerramilli D, Yang JT. Mathis NJ, et al. Among authors: brennan vs. Int J Radiat Oncol Biol Phys. 2022 Jan 1;112(1):99-105. doi: 10.1016/j.ijrobp.2021.06.025. Epub 2021 Oct 26. Int J Radiat Oncol Biol Phys. 2022. PMID: 34715255 Free PMC article.
Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy boost.
Kollmeier MA, Gorovets D, Flynn J, McBride S, Brennan V, Beaudry J, Cohen G, Damato A, Zhang Z, Zelefsky MJ. Kollmeier MA, et al. Brachytherapy. 2022 Sep-Oct;21(5):599-604. doi: 10.1016/j.brachy.2022.04.006. Epub 2022 Jun 17. Brachytherapy. 2022. PMID: 35725549 Free PMC article.
A Prospective Study Assessing the Efficacy and Toxicity of Stereotactic Body Radiation Therapy for Oligometastatic Bone Metastases.
Lee JH, Shi DD, Shin KY, Buckley E, Gunasti L, Hall E, Mann E, Spicer B, Chen YH, Hammoudeh L, Brennan V, Huynh MA, Spektor A, Krishnan MS, Balboni TA, Hertan LM. Lee JH, et al. Adv Radiat Oncol. 2023 Dec 6;9(4):101411. doi: 10.1016/j.adro.2023.101411. eCollection 2024 Apr. Adv Radiat Oncol. 2023. PMID: 38406391 Free PMC article.
Evaluating the Role of Stereotactic Body Radiation Therapy With Respect to Androgen Receptor Signaling Inhibitors for Oligometastatic Prostate Cancer.
Brennan V, Spektor A, Sweeney C, Choudhury A, Rathkopf D, Pomerantz M, Hertan L, Nguyen P, Martin N, Balboni T, Huynh MA, King M. Brennan V, et al. Adv Radiat Oncol. 2021 Sep 28;7(1):100808. doi: 10.1016/j.adro.2021.100808. eCollection 2022 Jan-Feb. Adv Radiat Oncol. 2021. PMID: 35071831 Free PMC article.
Risk analysis of the Unity 1.5 T MR-Linac adapt-to-position workflow.
Liang J, Scripes PG, Tyagi N, Subashi E, Wunner T, Cote N, Chan CY, Ng A, Brennan V, Zakeri K, Wildberger C, Mechalakos J. Liang J, et al. J Appl Clin Med Phys. 2023 Mar;24(3):e13850. doi: 10.1002/acm2.13850. Epub 2022 Nov 21. J Appl Clin Med Phys. 2023. PMID: 36411990 Free PMC article.
13 results